Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Jul 12, 2013 at 12:13 PM EDT

Will New Lung Cancer Drug FDA Approval Encourage More Smoking?

courtesy of NBN at German WikipediaThe news around tobacco and smoking cigarettes has been dominated by the trends around the…

Paul Ausick | Jul 12, 2013 at 8:30 AM EDT

WebMD Prescribes Higher Revenue and Profits

ThinkstockHealth information website WebMD Health Corp. (NASDAQ: WBMD) this morning raised its second-quarter estimates for revenues and profits, citing higher…

Jon C. Ogg | Jul 12, 2013 at 8:15 AM EDT

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that…

Jon C. Ogg | Jul 10, 2013 at 8:35 AM EDT

Other Medical Device Stocks at Risk After Intuitive Surgical Warning

ThinkstockIntuitive Surgical Inc. (NASDAQ: ISRG) has been the darling of momentum investors for years. Yesterday it gave short sellers the…

Mike Sauter | Jul 9, 2013 at 6:11 AM EDT

States That Drink the Most Beer

ThinkstockAfter falling for three straight years, U.S. beer consumption finally leveled off last year. In 2012, the country consumed 28.2…

247alex | Jul 2, 2013 at 4:03 PM EDT

Countries Spending the Most on Health Care

ThinkstockHistorically, health care spending among developed nations has grown considerably each year. However, beginning in 2010, spending has flattened. Based…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Jon C. Ogg | Jul 1, 2013 at 8:20 AM EDT

Top Biotech Stocks to Buy and Stocks to Short From PropThink

ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug…

Paul Ausick | Jul 1, 2013 at 7:35 AM EDT

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

ThinkstockCancer-drug developer Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) issued a terse press release yesterday, saying it had “received and rejected” a…

Douglas A. McIntyre | Jun 28, 2013 at 3:41 AM EDT

Pfizer Ups Stock Buyback to $10 Billion

Wikimedia CommonsIn a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it…

Paul Ausick | Jun 27, 2013 at 11:15 AM EDT

Employer-Sponsored Health Insurance on the Way Out?

ThinkstockA significant portion of employers that currently offer health insurance to their employees are likely to drop that benefit in…

Douglas A. McIntyre | Jun 27, 2013 at 4:18 AM EDT

Smoking Causes Cancer, and Depression

courtesy of NBN at German WikipediaSmoking may be bad for physical health, bad enough to cause dreaded diseases and death.…

Paul Ausick | Jun 25, 2013 at 11:20 AM EDT

Can Allergan Bounce Again?

ThinkstockPharmaceutical giant Allergan Inc. (NYSE: AGN) saw its stock climb to an all-time high of more than $116 a share…

Douglas A. McIntyre | Jun 25, 2013 at 6:08 AM EDT

For Kids, Living in Mississippi Sucks

ThinkstockIt is just as bad being a child living in Mississippi as it is being an adult. The same holds…

1 … 301 302 303 304 305 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Will New Lung Cancer Drug FDA Approval Encourage More Smoking?

WebMD Prescribes Higher Revenue and Profits

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Other Medical Device Stocks at Risk After Intuitive Surgical Warning

States That Drink the Most Beer

Countries Spending the Most on Health Care

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Top Biotech Stocks to Buy and Stocks to Short From PropThink

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Pfizer Ups Stock Buyback to $10 Billion

Employer-Sponsored Health Insurance on the Way Out?

Smoking Causes Cancer, and Depression

Can Allergan Bounce Again?

For Kids, Living in Mississippi Sucks

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Health and Healthcare Articles

All Health and Healthcare Articles

Will New Lung Cancer Drug FDA Approval Encourage More Smoking?

WebMD Prescribes Higher Revenue and Profits

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Other Medical Device Stocks at Risk After Intuitive Surgical Warning

States That Drink the Most Beer

Countries Spending the Most on Health Care

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Top Biotech Stocks to Buy and Stocks to Short From PropThink

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Pfizer Ups Stock Buyback to $10 Billion

Employer-Sponsored Health Insurance on the Way Out?

Smoking Causes Cancer, and Depression

Can Allergan Bounce Again?

For Kids, Living in Mississippi Sucks

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income